Jaks, STATs, cytokine signal transduction, and immunoregulation: Are we there yet?

Immunity

Volumn 7, Issue 1, 1997, Pages 1-11

  O'Shea, John J ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; JAK KINASE; JANUS KINASE; STAT PROTEIN; STAT1 PROTEIN; UNCLASSIFIED DRUG;

CARBOXY TERMINAL SEQUENCE; CELL TRANSFORMATION; ENZYME ISOLATION; IMMUNE RESPONSE; IMMUNOREGULATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; RECEPTOR GENE; REVIEW; SIGNAL TRANSDUCTION; ERRATUM; ERROR;

EID: 0030765924     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80505-1     Document Type: Review

References (132)

1. Abbas, A.K., Murphy, K.M., and Sher, A. (1996). Functional diversity of helper T lymphocytes. Nature 383, 787-793.
2. Adachi, M., Sekiya, M., Torigoe, T., Takayama, S., Reed, J.C., Miyazaki, T., Minami, Y., Taniguchi, T., and Imai, K. (1996). Interleukin-2 (IL-2) upregulates BAG-1 gene expression through serine-rich region within IL-2 receptor beta c chain. Blood 88, 4118-4123.
3. Adachi, M., Ishino, M., Torigoe, T., Minami, Y., Matozaki, T., Miyazaki, T., Taniguchi, T., Hinoda, Y., and Imai, K. (1997). Interleukin-2 induces tyrosine phosphorylation of SHP-2 through IL-2 receptor beta chain. Oncogene 14, 1629-1633.
4. Adler, K., Gerisch, G., von Hugo, U., Lupas, A., and Schweiger, A., (1996). Classification of tyrosine kinases from Dictyostelium discoideum with two distinct, complete or incomplete catalytic domians. FEBS Lett. 395, 286-292.
5. Ali, S., Chen, Z., Lebrun, J.J., Vogel, W., Kharitonenkov, A., Kelly, P.A., and Ullrich, A. (1996). PTP1D is a positive regulator of the prolactin signal leading to beta-casein promoter activation. EMBO J 15, 135-142.
6. Bacon, C.M., Petricoin, E.F.R., Ortaldo, J.R., Rees, R.C., Larner, A.C., Johnston, J.A., and O'Shea, J.J. (1995). Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc. Natl. Acad. Sci. USA 92, 7307-7311.
7. Bazan, J.F. (1990). Haemopoietic receptors and helical cytokines. Immunol. Today 11, 350-354.
8. Beadling, C., Ng, J., Babbage, J.W., and Cantrell, D.A. (1996). Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway. EMBO J. 15, 1902-1913.
9. Bhattacharya, S., Eckner, R., Grossman, S., Oldread, E., Arany, Z., D'Andrea, A., and Livingston, D.M. (1996). Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha. Nature 383, 344-347.
10. Binari, R., and Perrimon, N. (1994). Stripe-specific regulation of pair-rule genes by hopscotch, a putative Jak family tyrosine kinase in Drosophila. Genes Dev. 8, 300-312.
11. Boulton, T.G., Zhong, Z., Wen, Z., Darnell, J.E.J., Stahl, N., and Yancopoulos, G.D. (1995). STATS activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an H7-sensitive kinase. Proc. Natl. Acad. Sci. USA 92, 6915-6919.
12. Boussiotis, V.A., Barber, D.L., Nakarai, T., Freeman, G.J., Gribben, J.G., Bernstein, G.M., D'Andrea, A.D., Ritz, J., and Nadler, L.M. (1994). Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor. Science 266, 1039-1042.
13. Cao, X., Shores, E.W., Hu-Li, J., Anver, M.R., Kelsall, B.L, Russell, S.M., Drago, J., Noguchi, M., Grinberg, A., Bloom, ET., et al. (1995). Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 2, 223-238.
14. Cao, X., Tay, A., Guy, G.R., and Tan, Y.H. (1996). Activation and association of Stat3 with Src in v-Src-transformed cell lines. Mol. Cell. Biol. 16, 1595-1603.
15. Carlesso, N., Frank, D.A., and Griffin, J.D. (1996). Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J. Exp. Med. 183, 811-820.
16. Chen, M., Cheng, A., Chen, Y.Q., Hymel, A., Hanson, E.P., Kimmel, L., Minami, Y., Taniguchi, T., Changelian, P.S., and O'Shea, J.J. (1997). The amino terminus of JAK3 is necessary and sufficient for binding to the common γ chain and confers the ability to transmit interleukin 2-mediated signals. Proc. Natl. Acad. Sci. USA 94, 6910-6915.
17. Chin, Y.E., Kitagawa, M., Su, W.C., You, Z.H., Iwamoto, Y., and Fu, X.Y. (1996). Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science 272, 719-722.
18. Cho, S.S., Bacon, C.M., Sudarshan, C., Rees, R.C., Finbloom, D., Pine, R., and O'Shea, J.J. (1996). Activation of STAT4 by IL-12 and IFN-alpha: evidence for the involvement of ligand-induced tyrosine and serine phosphorylation. J Immunol 157, 4781-4789.
19. Conway, G., Margoliath, A., Wong-Madden, S., Roberts, R.J., and Gilbert, W. (1997). Jak1 kinase is required for cell migrations and anterior specification in zebrafish embryos. Proc. Natl. Acad. Sci. USA 94, 3082-3087.
20. Danial, N.N., Pernis, A., and Rothman, P.B. (1995). Jak-STAT signaling induced by the v-abl oncogene. Science 269, 1875-1877.
21. Darnell, J.E.J., Kerr, I.M., and Stark, G.R. (1994). Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421.
22. David, M., Petricoin, E.R., Benjamin, C., Pine, R., Weber, M.J., and Larner, A.C. (1995). Requirement for MAP kinase (ERK2) activity in interferon alpha-and interferon beta-stimulated gene expression through STAT proteins [see comments]. Science 269, 1721-1723.
23. Dent, A.L., Shaffer, A.L., Yu, X., Allman, D., and Staudt, L.M. (1997). Control of inflammation, cytokine expression and germinal center formation by BCL-6. Science 276, 589-592.
24. DiSanto, J.P., Muller, W., Guy-Grand, D., Fischer, A., and Rajewsky, K. (1995). Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc. Natl. Acad. Sci. USA 92, 377-381.
25. Durbin, J.E., Hackenmiller, R., Simon, M.C., and Levy, D.E. (1996). Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84, 443-450.
26. Feng, J., Witthuhn, B.A., Matsuda, T., Kohlhuber, F., Kerr, I.M., and IhIe, J.N. (1997). Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop. Mol. Cell. Biol. 17, 2497-2501.
27. Frank, S.J., Gilliland, G., Kraft, A.S., and Arnold, C.S. (1994). Interaction of the growth hormone receptor cytoplasmic domain with the Jak2 tyrosine kinase. Endocrinology 135, 2228-2239.
28. Fu, X.Y. (1992). A transcription factor with SH2 and SH3 domains is directly activated by an interferon alpha-induced cytoplasmic protein tyrosine kinase(s). Cell 70, 323-335.
29. Fujitani, Y., Hibi, M., Fukada, T., Takahashitezuka, M., Yoshida, H., Yamaguchi, T., Sugiyama, K., Yamanaka, Y., Nakajima, K., and Hirano, T. (1997). An alternative pathway for STAT activation that is mediated by the direct interaction between Jak and STAT. Oncogene 14, 751-761.
30. Gauzzi, M.C., Velazquez, L., McKendry, R., Mogensen, K.E., Fellous, M., and Pellegrini, S. (1996). Interferon-alpha-dependent activation of Tyk2 requires phosphorylation of positive regulatory tyrosines by another kinase. J. Biol. Chem. 271, 20494-20500.
31. Ghilardi, N., Ziegler, S., Wiestner, A., Stoffel, R, Heim, M.H., and Skoda, R.C. (1996). Defective STAT signaling by the leptin receptor in diabetic mice. Proc. Natl. Acad. Sci. USA 93, 6231-6235.
32. Gouilleux-Gruart, V., Gouilleux, F., Desaint, C., Claisse, J.F., Capiod, J.C., Delobel, J., Weber-Nordt, R., Dusanter-Fourt, I., Dreyfus, F., Groner, B., and Prin, L. (1996). STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. Blood 87, 1692-1697.
33. Greenlund, A.C., Farrar, M.A., Viviano, B.L., and Schreiber, R.D. (1994). Ligand-induced IFNγ receptor phosphorylation couples the receptor to its signal transduction system (p91). EMBO J. 13, 1591-1600.
34. Greenlund, A.C., Morales, M.O., Viviano, B.L., Yan, H., Krolewski, J., and Schreiber, R.D. (1995). Stat recruitment by tyrosine-phosphorylated cytokine receptors: an ordered reversible affinity-driven process. Immunity 2, 677-687.
35. Hanissian, S.H., and Geha, R.S. (1997). Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells. Immunity 6, 379-387.
36. Hanratty, W.P., and Dearolf, C.R. (1993). The DrosophilaTumorouslethal hematopoietic oncogene is a dominant mutation in the hopscotch locus. Mol. Gen. Genet. 238, 33-37.
37. Harrison, D.A., Binari, R., Nahreini, T.S., Gilman, M., and Perrimon, N. (1995). Activation of a Drosophila Janus kinase (Jak) causes hematopoietic neoplasia and developmental defects. EMBO J. 14, 2857-2865.
38. Haspel, R.L., Salditt-Georgieff, M., and Darnell, J.E.J. (1996). The rapid inactivation of nuclear tyrosine phosphorylated Stat1 depends upon a protein tyrosine phosphatase. EMBO J. 15, 6262-6268.
39. Heim, M.H., Kerr, I.M., Stark, G.R., and Darnell, J.E.J. (1995). Contribution of STAT SH2 groups to specific interferon signaling by the Jak-STAT pathway. Science 267, 1347-1349.
40. Horvath, C.M., Wen, Z., and Darnell, J.E.J. (1995). A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev. 9, 984-994.
41. Hou, J., Schindler, U., Henzel, W.J., Ho, T.C., Brasseur, M., and McKnight, S.L. (1994). An interleukin-4-induced transcription factor: IL-4 Stat. Science 265, 1701-1706.
42. Hou, X.S., Melnick, M.B., and Perrimon, N. (1996). marelle acts downstream of the Drosophila HOP/Jak kinase and encodes a protein similar to the mammalian STATs. Cell 54, 411-419.
43. Hou, X.S., and Perrimon, N. (1997). The Jak-STAT pathway in Drosophila. Trends Genet. 13, 105-110.
44. Ihle, J.N. (1995). Cytokine receptor signalling. Nature 377, 591-594.
45. Ihle, J.N., Witthuhn, B.A., Quelle, F.W., Yamamoto, K., and Silvennoinen, O. (1995). Signaling through the hematopoietic cytokine receptors. Annu. Rev. Immunol. 13, 369-398.
46. Ihle, J.N. (1996). STATs: signal transducers and activators of transcription. Cell 84, 331-334.
47. Ilaria, R.L. J., and Van Etten, R.A. (1996). P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members. J. Biol. Chem. 271, 31704-31710.
48. Jacobson, N.G., Szabo, S.J., Weber-Nordt, R.M., Zhong, Z., Schreiber, R.D., Darnell, J.E.J., and Murphy, K.M. (1995). Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4. J. Exp. Med. 181, 1755-1762.
49. Johnston, J.A., Bacon, C.M., Riedy, M.C., and O'Shea, J.J. (1996). Signaling by IL-2 and related cytokines: Jaks, STATs, and relationship to immunodeficiency. J. Leukocyte Biol. 60, 441-452.
50. Kanwar, V.S., Witthuhn, B., Campana, D., and Ihle, J.N. (1996). Lack of constitutive activation of Janus kinases and signal transduction and activation of transcription factors in Philadelphia chromosome-positive acute lymphoblastic leukemia [letter]. Blood 87, 4911-4912.
51. Kaplan, M.H., Schindler, U., Smiley, ST., and Grusby, M.J. (1996). State is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4, 313-319.
52. Kaplan, M.H., Sun, Y.L., Hoey, T., and Grusby, M.J. (1996). Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382, 174-177.
53. Kawahara, A., Minami, Y., Miyazaki, T., Ihle, J.N., and Taniguchi, T. (1995). Critical role of the interleukin 2 (IL-2) receptor gamma-chain-associated Jak3 in the IL-2-induced c-fos and c-myc, but not bcl-2, gene induction. Proc. Natl. Acad. Sci. USA 92, 8724-8728.
54. Kawata, T., Shevchenko, A., Fukuzawa, M., Jermyn, K.A., Totty, N.F., Zhukovskaya, N.V., Sterling, A.E., Mann, M., and Williams, J.G., (1997). SH2 signaling in a lower eukaryote: a STAT protein that regulates stalk cell differentiation in Dictyostelium. Cell 89, 909-916.
55. Kim, T.K., and Maniatis, T. (1996). Regulation of interferon-gamma-activated STAT1 by the ubiquitin-proteasome pathway. Science 273, 1717-1719.
56. Klingmuller, U., Lorenz, U., Cantley, L.C., Neel, B.G., and Lodish, H.F. (1995). Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of Jak2 and termination of proliferative signals. Cell 80, 729-738.
57. Kohlhuber, F., Rogers, N.C., Watling, D., Feng, J., Guschin, D., Briscoe, J., Witthuhn, B.A., Kotenko, S.V., Pestka, S., Stark, G.R., et al. (1997). A JAK1/JAK2 chimera can sustain alpha and gamma interferon responses. Mol. Cell. Biol. 17, 695-706.
58. Kopf, M., Le Gros, G., Bachmann, M., Lamers, M.C., Bluethmann, H., and Kohler, G. (1993). Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362, 245-248.
59. Kuhn, R., Rajewsky, K., and Muller, W. (1991). Generation and analysis of interleukin-4 deficient mice. Science 254, 707-710.
60. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K., and Muller, W. (1993). Interleukin-10-deficient mice develop chronic enterocolitis [see comments]. Cell 75, 263-274.
61. Kundig, T.M., Schorle, H., Bachmann, M.F., Hengartner, H., Zinkernagel, R.M., and Horak, I. (1993). Immune responses in interleukin-2-deficient mice. Science 262, 1059-1061.
62. Lai, K.S., Jin, Y., Graham, D.K., Witthuhn, B.A., Ihle, J.N., and Liu, E.T. (1995). A kinase-deficient splice variant of the human Jak3 is expressed in hematopoietic and epithelial cancer cells. J. Biol. Chem. 270, 25028-25036.
63. Leonard, W.J. (1996). The molecular basis of X-linked severe combined immunodeficiency: defective cytokine receptor signaling. Annu. Rev. Med. 47, 229-239.
64. Leung, S., Qureshi, S.A., Kerr, I.M., Darnell, J.E.J., and Stark, G.R. (1995). Role of STAT2 in the alpha interferon signaling pathway. Mol. Cell. Biol. 15, 1312-1317.
65. Li, X., Leung, S., Kerr, I.M., and Stark, G.R. (1997). Functional subdomains of STAT2 required for preassociation with the alpha interferon receptor and for signaling. Mol. Cell. Biol. 17, 2048-2056.
66. Liu, X., Robinson, G.W., Wagner, K.U., Garrett, L., Wynshaw-Boris, A., and Hennighausen, L. (1997). Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 11, 179-186.
67. Longmore, G.D., and Lodish, H.F. (1991). An activating mutation in the murine erythropoietin receptor induces erythroleukemia in mice: a cytokine receptor superfamily oncogene. Cell 67, 1089-1102.
68. Luo, H., Hanratty, W.P., and Dearolf, C.R. (1995). An amino acid substitution in the Drosophila hopTum-I Jak kinase causes leukemia-like hematopoietic defects. EMBO J. 14, 1412-1420.
69. Luo, H., Rose, P., Barber, D., Hanratty, W.P., Lee, S., Roberts, T.M., DAndrea, A.D., and Dearolf, C.R. (1997). Mutation in the Jak kinase JH2 domain hyperactivates Drosophila and mammalian Jak-STAT pathways. Mol. Cell. Biol. 17, 1562-1571.
70. Macchi, P., Villa, A., Gillani, S., Sacco, M.G., Frattini, A., Porta, F., Ugazio, A.G., Johnston, J.A., Candotti, F., O'Shea, J.J., et al. (1995). Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 377, 65-68.
71. Magram, J., Connaughton, S.E., Warrier, R.R., Carvajal, D.M., Wu, C.Y., Ferrante, J., Stewart, C., Sarmiento, U., Faherty, D.A., and Gately, M.K. (1996). IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 4, 471-481.
72. Meinke, A., Barahmand-Pour, F., Wohrl, S., Stoiber, D., and Decker, T. (1996). Activation of different Stat5 isoforms contributes to cell-type-restricted signaling in response to interferons. Mol. Cell. Biol. 16, 6937-6944.
73. Meraz, M.A., White, J.M., Sheehan, K.C., Bach, E.A., Rodig, S.J., Dighe, A.S., Kaplan, D.H., Riley, J.K., Greenlund, A.C., Campbell, D., et al. (1996). Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the Jak-STAT signaling pathway. Cell 84, 431-442.
74. Meydan, N., Grunberger, T., Dadi, H., Shahar, M., Arpaia, E., Lapidot, Z., Leeder, J.S., Freedman, M., Cohen, A., Gazit, A., Levitzki, A., and Roifman, C.M. (1996). Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 379, 645-648.
75. Migone, T.S., Lin, J.X., Cereseto, A., Mulloy, J.C., O'Shea, J.J., Franchini, G., and Leonard, W.J. (1995). Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science 269, 79-81.
76. Miyazaki, T., Kawahara, A., Fujii, H., Nakagawa, Y., Minami, Y., Liu, Z. J., Oishi, I., Silvennoinen, O., Witthuhn, B.A., Ihle, J.N., et al. (1994). Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science 266, 1045-1047.
77. Muller, M., Briscoe, J., Laxton, C., Guschin, D., Ziemieck, A., Silvennoinen, O., Harpun, A.G., Barbieri, G., Witthuhn, B.A., Schindler, C., et al. (1993a). The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction. Nature 366, 129-135.
78. Muller, M., Laxton, C., Briscoe, J., Schindler, C., Improta, T., Darnell, J.E.J., Stark, G.R., and Kerr, I.M. (1993b). Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-alpha and -gamma signal transduction pathways. EMBO J. 12, 4221-4228.
79. Nakajima, Hm, Shores, E.W., Noguchi, M., and Leonard, W.J. (1997). The common cytokine receptor γ chain plays an essential role in regulating lymphoid homeostasis. J. Exp. Med. 185, 189-196.
80. Noguchi, M., Yi, H., Rosenblatt, H.M., Filipovich, A.H., Adelstein, S., Modi, W.S., McBride, O.W., and Leonard, W.J. (1993). Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73, 147-157.
81. Nosaka, T., van Deursen, J.M., Tripp, R.A., Thierfelder, W.E., Witthuhn, B.A., McMickle, A.P., Doherty, P.C., Grosveld, G.C., and Ihle, J.N. (1995). Defective lymphoid development in mice lacking Jak3. Science 270, 800-802.
82. Ohashi, T., Masuda, M., and Ruscetti, S.K. (1996). Activation of stat-related DNA-binding factors by erythropoietin and the spleen focus-forming virus. Curr. Topics Microbiol. Immunol. 211, 223-231.
83. Park, S.Y., Saijo, K., Takahashi, T., Osawa, M., Arase, H., Hirayama, N., Miyake, K., Nakauchi, H., Shirasawa, T., and Saito, T. (1995). Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity 3, 771-782.
84. Paul, W.E., and Seder, R.A. (1994). Lymphocyte responses and cytokines. Cell 76, 241-251.
85. Peschon, J.J., Morrissey, P.J., Grabstein, K.H., Ramsdell, F.J., Maraskovsky, E., Gliniak, B.C., Park, L.S., Ziegler, S.F., Williams, D.E., Ware, C.B., and et al (1994). Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180, 1955-1960.
86. Pfeffer L. M., Mullersman, J.E., Pfeffer, S.R., Murti, A., Shi, W., Yang, C.H. (1997). STAT3 as an adapter to couple phosphatidylinositol 3-kinase to the IFNAR1 chain of the type 1 interferon receptor. Science 276, 1418-1420.
87. Rogge, L., Barberismaino, L., Biffi, M., Passini, N., Presky, D.H., Gubler, U., and Sinigaglia, F. (1997). Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185, 825-831.
88. Russell, S.M., Johnston, J.A., Noguchi, M., Kawamura, M., Bacon, C.M., Friedmann, M., Berg, M., McVicar, D.W., Witthuhn, B.A., Silvennoinen, O., et al. (1994). Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. Science 266, 1042-1045.
89. Russell, S.M., Tayebi, N., Nakajima, H., Riedy, M.C., Roberts, J.L., Aman, M.J., Migone, T.S., Noguchi, M., Markert, M.L., Buckley, R.H., et al. (1995). Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 270, 797-800.
90. Sadlack, B., Merz, H., Schorle, H., Schimpl, A., Feller, A.C., and Horak, I. (1993). Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75, 253-261.
91. Sadowski, H.B., Shuai, K., Darnell, J.E.J., and Gilman, M.Z. (1993). A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science 261, 1739-1744.
92. Saijo, K., Park, S.Y., Ishida, Y., Arase, H., and Saito, T. (1997). Crucial role of Jak3 in negative selection of self-reactive T cells. J. Exp. Med. 185, 351-356.
93. Schindler, C., Shuai, K., Prezioso, V.R., and Darnell, J.E.J. (1992) Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 257, 807-813.
94. Schindler, C., and Darnell, J.E.J. (1995). Transcriptional responses to polypeptide ligands: the Jak-STAT pathway. Annu. Rev. Biochem. 64, 621-651.
95. Schindler, U., Wu, P., Rothe, M., Brasseur, M., and McKnight, S.L. (1995). Components of a Stat recognition code: evidence for two layers of molecular selectivity. Immunity 2, 689-697.
96. Seidel, H.M., Milocco, L.H., Lamb, P., Darnell, J.E.J., Stein, R.B., and Rosen, J. (1995). Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc. Natl. Acad. Sci. USA 92, 3041-3045.
97. Shimoda, K., van Deursen, J., Sangster, M.Y., Sarawar, S.R., Carson, R.T., Tripp, R.A., Chu, C., Quelle, F.W., Nosaka, T., Vignali, D.A., et al. (1996). Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380, 630-633.
98. Shuai, K., Schindler, C., Prezioso, V.R., and Darnell, J.E.J. (1992). Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein. Science 258, 1808-1812.
99. Shuai, K., Stark, G., Kerr, I,M, and Darnell, J.E.J. (1993). A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. Science 261, 1744-1746.
100. Shuai, K., Horvath, C.M., Huang, L.H., Qureshi, S.A., Cowburn, D., and Darnell, J.E.J. (1994). Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions. Cell 76, 821-828.
101. Shuai, K., Halpern, J., ten Hoeve, J., Rao, X., and Sawyers, C.L. (1996). Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia. Oncogene 13, 247-254.
102. Silvennoinen, O., Ihle, J.N., Schlessinger, J., and Levy, D.E. (1993). Interferon-induced nuclear signalling by Jak protein tyrosine kinases. Nature 366, 583-585.
103. Souyri, M., Vigon, I., Penciolelli, J.F., Heard, J.M., Tambourin, P., and Wendling, F. (1990). A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors. Cell 63, 1137-1147.
104. Stahl, N., Farruggella, T.J., Boulton, T.G., Zhong, Z., Darnell, J.E.J., and Yancopoulos, G.D. (1995). Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 267, 1349-1353.
105. Stocklin, E., Wissler, M., Gouilleux, F., and Groner, B. (1996). Functional interactions between Stat5 and the glucocorticoid receptor. Nature 383, 726-728.
106. Suzuki, H., Kundig, T.M., Furlonger, C., Wakeham, A., Timms, E., Matsuyama, T., Schmits, R., Simard, J.J., Ohashi, P.S., Griesser, H., et al. (1995). Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 268, 1472-1476.
107. Szabo, S.J., Dighe, A.S., Gubler, U., and Murphy, K.M. (1997). Regulation of the interleukin (IL)-12R beta-2-subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185, 817-824.
108. Taga, T., and Kishimoto, T. (1995). Signaling mechanisms through cytokine receptors that share signal transducing receptor components. Curr. Opin. Immunol. 7, 17-23.
109. Takeda, K., Tanaka, T., Shi, W., Matsumoto, M., Minami, M., Kashiwamura, S., Nakanishi, K., Yoshida, N., Kishimoto, T., and Akira, S. (1996). Essential role of Stat6 in IL-4 signalling. Nature 380, 627-630.
110. Takeda, K., Noguchi, K., Shi, W., Tanaka, T., Matsumoto, M., Yoshida, N., Kishimoto, T., and Akira, S. (1997). Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. USA 94, 3801-3804.
111. Takeshita, T., Arita, T., Higuchi, M., Asao, H., Endo, K., Kuroda, H., Tanaka, N., Marata, K., Ishii, N., and Sugamura, K. (1997). STAM, signal transducing adaptor molecule, is associated with janus kinases and involved in signaling for cell growth and c-myc induction. Immunity 6, 449-457.
112. Thierfelder, W.E., van Deursen, J.M., Yamamoto, K., Tripp, R.A., Sarawar, S.R., Carson, R.T., Sangster, M.Y., Vignali, D.A., Doherty, P.C., Grosveld, G.C., and Ihle, J.N. (1996). Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382, 171-174.
113. Thomis, D.C., and Berg, L.J. (1997). Peripheral expression of Jak3 is required to maintain T lymphocyte function. J. Exp. Med. 185, 197-206.
114. Thomis, D.C., Gurniak, C.B., Tivol, E., Sharpe, A.H., and Berg, L.J. (1995). Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science 270, 794-797.
115. Velazquez, L., Fellous, M., Stark, G.R., and Pellegrini, S. (1992). A protein tyrosine kinase in the interferon α/β signaling pathway. Cell 70, 313-322.
116. Velazquez, L., Mogensen, K.E., Barbieri, G., Fellous, M., Uze, G., and Pellegrini, S. (1995). Distinct domains of the protein tyrosine kinase tyk2 required for binding of interferon-alpha/beta and for signal transduction. J. Biol. Chem. 270, 3327-3334.
117. von Freeden-Jeffry, U., Vieira, P., Lucian, L.A., McNeil, T., Burdach, S.E., and Murray, R. (1995). Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181, 1519-1526.
118. Wang, D., Stravopodis, D., Teglund, S., Kitazawa, J., and Ihle, J.N. (1996). Naturally occurring dominant negative variants of Stat5. Mol. Cell. Biol. 16, 6141-6148.
119. Watling, D., Guschin, D., Muller, M., Silvennoinen, O., Witthuhn, B.A., Quelle, F.W., Rogers, N.C., Schindler, C., Stark, G.R., Ihle, J.N., et al. (1993). Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway [see comments]. Nature 366, 166-170.
120. Weber-Nordt, R.M., Egen, C., Wehinger, J., Ludwig, W., Gouilleux-Gruart, V., Mertelsmann, R., and Fink, J. (1996). Constitutive action of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood 88, 809-816.
121. Wen, Z., Zhong, Z., and Darnell, J.E.J. (1995). Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82, 241-250.
122. Willerford, D.M., Chen, J., Ferry, J.A., Davidson, L., Ma, A., amd Alt, F.W. (1995). Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3, 521-530.
123. Xu, X., Sun, Y.L., and Hoey, T. (1996). Cooperative DNA binding and sequence-selective recognition conferred by the STAT aminoterminal domain [see comments]. Science 273, 794-797.
124. Yan, H., Krishnan, K., Greenlund, A.C., Gupta, S., Lim, J.T., Schreiber, R.D., Schindler, C.W., and Krolewski, J.J. (1996a). Phosphorylated interferon-alpha receptor 1 subunit (IFNαR1) acts as a docking site for the latent form of the 113 kDa STAT2 protein. EMBO J. 15, 1064-1074.
125. Yan, H., Krishnan, K., Lim, J.T., Contillo, L.G., and Krolewski, J.J. (1996b). Molecular characterization of an alpha interferon receptor 1 subunit (IFNαR1) domain required for the TYK2 binding and signal transduction. Mol. Cell. Biol. 16, 2074-2082.
126. Yan, R., Luo, H., Darnell, J.E.J., and Dearolf, C.R. (1996c). A JAK-STAT pathway regulates wing vein formation in Drosophila. Proc. Natl. Acad. Sci. USA 93, 5842-5847.
127. Yan, R., Small, S., Desplan, C., Dearolf, C.R., and Darnell, J.E.J. (1996d). Identification of a Stat gene that functions in Drosophila development. Cell 84, 421-430.
128. Yin, T., Shen, R, Feng, G.S., and Yang, Y.C. (1997). Molecular characterization of specific interactions between SHP-2 phosphatase and JAK tyrosine kinases. J. Biol. Chem. 272, 1032-1037.
129. Yu, C.L., Meyer, D.J., Campbell, G.S., Larner, A.C., Carter-Su, C., Schwartz, J., and Jove, R. (1995). Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269, 81-83.
130. Zhang, X., Blenis, J., Li, H.C., Schindler, C., and Chen-Kiang, S. (1995). Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science 267, 1990-1994.
131. Zhang, Q., Nowack, I., Vonderheid, E.C., Rook, A.H., Kadin, M.E., Nowell, P.C., Shaw, L.M., and Wasik, M.A. (1996). Activation of Jak/ STATproteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Proc. Natl. Acad. Sci. USA 93, 9148-9153.
132. Zhao, Y., Wagner, F., Frank, S.J., and Kraft, A.S. (1995). The aminoterminal portion of the JAK2 protein kinase is necessary for binding and phosphorylation of the granulocyte-macrophage colony-stimulating factor receptor beta c chain. J. Biol. Chem. 270, 13814-13818.